Consistently, the ZNF506 gene is frequently dysregulated in various cancers including lung and breast cancers, where low ZNF506 mRNA levels in breast and lung cancers correlated with lower survival probability and worse prognosis (Supplementary Fig. 4h–i)38,39. This evidence concerns the gene ZNF506 and breast carcinoma.